Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Body Fluid Collection And Diagnostics Market, by Product
1.4.2 North America Body Fluid Collection And Diagnostics Market, by Technology
1.4.3 North America Body Fluid Collection And Diagnostics Market, by Sample Type
1.4.4 North America Body Fluid Collection And Diagnostics Market, by Application
1.4.5 North America Body Fluid Collection And Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2021, Jan – 2022, Sep) Leading Players
Chapter 4. North America Body Fluid Collection And Diagnostics Market by Product
4.1 North America Kits & Consumables Market by Country
4.2 North America Instruments Market by Country
4.3 North America Tests/Services Market by Country
Chapter 5. North America Body Fluid Collection And Diagnostics Market by Technology
5.1 North America Polymerase Chain Reaction (PCR) Market by Country
5.2 North America Next Generation Sequencing (NGS) Market by Country
5.3 North America Fluorescence in situ hybridization (FISH) Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Body Fluid Collection And Diagnostics Market by Sample Type
6.1 North America Blood Market by Country
6.2 North America Urine Market by Country
6.3 North America Saliva Market by Country
6.4 North America Cerebrospinal Fluid Market by Country
Chapter 7. North America Body Fluid Collection And Diagnostics Market by Application
7.1 North America Diagnostics & Monitoring Market by Country
7.2 North America Therapeutic Decision Making Market by Country
7.3 North America Prognostics & Screening Market by Country
Chapter 8. North America Body Fluid Collection And Diagnostics Market by Country
8.1 US Body Fluid Collection And Diagnostics Market
8.1.1 US Body Fluid Collection And Diagnostics Market by Product
8.1.2 US Body Fluid Collection And Diagnostics Market by Technology
8.1.3 US Body Fluid Collection And Diagnostics Market by Sample Type
8.1.4 US Body Fluid Collection And Diagnostics Market by Application
8.2 Canada Body Fluid Collection And Diagnostics Market
8.2.1 Canada Body Fluid Collection And Diagnostics Market by Product
8.2.2 Canada Body Fluid Collection And Diagnostics Market by Technology
8.2.3 Canada Body Fluid Collection And Diagnostics Market by Sample Type
8.2.4 Canada Body Fluid Collection And Diagnostics Market by Application
8.3 Mexico Body Fluid Collection And Diagnostics Market
8.3.1 Mexico Body Fluid Collection And Diagnostics Market by Product
8.3.2 Mexico Body Fluid Collection And Diagnostics Market by Technology
8.3.3 Mexico Body Fluid Collection And Diagnostics Market by Sample Type
8.3.4 Mexico Body Fluid Collection And Diagnostics Market by Application
8.4 Rest of North America Body Fluid Collection And Diagnostics Market
8.4.1 Rest of North America Body Fluid Collection And Diagnostics Market by Product
8.4.2 Rest of North America Body Fluid Collection And Diagnostics Market by Technology
8.4.3 Rest of North America Body Fluid Collection And Diagnostics Market by Sample Type
8.4.4 Rest of North America Body Fluid Collection And Diagnostics Market by Application
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.2 Guardant Health, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Qiagen N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Bio-Rad Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 Laboratory Corporation of America Holdings
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 Recent strategies and developments:
9.7.4.1 Partnerships, Collaborations, and Agreements:
9.8 Johnson & Johnson
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental &Regional Analysis
9.8.4 Research & Development Expenses
9.9 Biocept, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expenses
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. MDxHealth SA
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
Unique Offerings 